News and Announcements
What Investors Look For In Each Startup Stage
- Published December 20, 2022 3:22AM UTC
- Publisher Leila Oliveira
- Categories Capital Raising Tips
What investors are looking for in each stage of your startup:
– Pre-seed
You are selling a vision of what it could be instead of what you’ve already done.
Focus on: Team experience, your secret sauce, a great pitch deck and market opportunity.
– Seed
What evidence do you already have that this will be successful?
Focus on: Pre-seed metrics + EOI/active users/early traction/followers and engagement on social media. Anything that can showcase the demand for the product.
– Series A
How much can you scale this business in the next 12-15 months?
Focus on: Seed metrics + existing investors, strong board management, growth metrics
-Series B and Beyond
Investors are looking for liquidity. When and how is it happening?
Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Capital Raising Tips
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
